Endothelial dysfunction and coronary artery disease: new insights from reactive hyperemia test

Abstract

Aim: The percentage variation of Resistance Index (△RI%) after reactive hyperemia test at the brachial artery is a marker of endothelial dysfunction that could be used as a surrogate indicator for the extent of coronary artery disease (CAD). We assessed flow-mediated dilatation (FMD) and △RI% in 39 consecutive patients undergoing coronary angiography.

Methods: Patients were classified in groups 0 to 3 according to the number of diseased vessels and the SYNTAX score was calculated. The hyperemia reactive test was performed 1 day before to 3 days after coronary angiography.

Results: Both FMD and △RI% decreased significantly from groups 0 to 3 (ANOVA P < 0.001 and P = 0.002, respectively). Reduced △RI% was linearly associated with SYNTAX score (β = 0.34, P = 0.036). At multivariable modeling, impaired △RI% was the only significant independent predictor of the presence of CAD (OR = 1.28, 95%CI: 1.06-1.54, P = 0.01).

Conclusion: This study shows that a reduced △RI% after reactive hyperemia test is observed in patients with CAD and that such reduction is related to the extent of the disease. Therefore, to evaluate FMD and △RI% at the brachial artery can reliably indicate the burden of CAD.

Keywords

Endothelial dysfunction / post-ischemic reactive hyperemia / coronary artery disease / flow-mediated dilation

References

[1] Laurent S,Brunel P,Pannier B.Flow-dependent vasodilation of brachial artery in essential hypertension.Am J Physiol1990;258:H1004-11

[2] Mäkimattila S,Vakkilainen J.Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.Diabetes care1999;22:973-81

[3] Guzik TJ,Black E.Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors.Circ Res2000;86:E85-90

[4] Bonetti PO,Lerman A.Endothelial dysfunction: a marker of atherosclerotic risk.Arterioscler Thromb Vasc Biol2003;23:168-75

[5] Dikalov S,Richmond B.Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension.Am J Physiol Heart Circ Physiol2019;316:H639-46 PMCID:PMC6459311

[6] Corretti MC,Benjamin EJ.International Brachial Artery Reactivity Task ForceGuidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.J Am Coll Cardiol2002;39:257-65

[7] Alexander Y,Schmidt-Trucksäss A.Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and Thrombosis.Cardiovasc Res2021;117:29-42 PMCID:PMC7797212

[8] Anderson TJ,Gerhard MD.Close relation of endothelial function in the human coronary and peripheral circulations.J Am Coll Cardiol1995;26:1235-41

[9] Takase B,Akima T.Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease.Am J Cardiol1998;82:1535-9

[10] Manganaro A,Andrè L.Endothelial dysfunction in patients with coronary artery disease: insights from a flow-mediated dilation study.Clin Appl Thromb Hemost2014;20:583-8

[11] Yeboah J,Hsu FC,Herrington DM.Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study.Circulation2007;115:2390-7

[12] Shechter M,Koren-Morag N,Hiersch L.Usefulness of brachial artery flow-mediated dilation to predict long-term cardiovascular events in subjects without heart disease.Am J Cardiol2014;113:162-7

[13] Anderson TJ,Title LM.Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.Circulation2011;123:163-9

[14] Lind L,Larsson A.Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease.Circulation2011;123:1545-51

[15] Tublin ME,Platt JF.Review. The resistive index in renal Doppler sonography: where do we stand?.AJR Am J Roentgenol2003;180:885-92

[16] Manganaro A,Salvo A,Coppolino F.A comparison of Power Doppler with conventional sonographic imaging for the evaluation of renal artery stenosis.Cardiovasc Ultrasound2004;2:1 PMCID:PMC324567

[17] Manganaro A,Buda D.Plaque Topographic Characterization: A New Element to Investigate Carotid Atherosclerosis.Ultrasound Med Biol2017;43:1557-8

[18] Heitzer T,Krohn K,Münzel T.Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.Circulation2001;104:2673-8

[19] Kaku B,Ohsato K.The correlation between coronary stenosis index and flow-mediated dilation of the brachial artery.Jpn Circ J1998;62:425-30

[20] Wu TC,Chen JW.Impaired forearm reactive hyperemia is related to late restenosis after coronary stenting.Am J Cardiol2000;85:1071-6

[21] Donald AE,Charakida M.Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation.J Am Coll Cardiol2008;51:1959-64

[22] Philpott AC,Title LM.Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors.Am J Cardiol2009;103:1610-5

[23] Järhult SJ,Ahlström H,Sundström J.Brachial artery hyperaemic blood flow velocity in relation to established indices of vascular function and global atherosclerosis: the Prospective Investigation of the Vasculature in Uppsala Seniors study.Clin Physiol Funct Imaging2012;32:227-33

[24] Järhult SJ,Lind L.Hyperaemic blood-flow velocities in systole and diastole relate to coronary risk in divergent ways.Clin Physiol Funct Imaging2008;28:189-95

[25] Sianos G,Kappetein AP.The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.EuroIntervention2005;1:219-27

[26] Yadav M,Caixeta A.Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery.J Am Coll Cardiol2013;62:1219-30

[27] Suzuki T,Elkind MS.Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS).Am Heart J2008;156:405-10 PMCID:PMC2597726

[28] Kunadian V,Camici PG.An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European society of cardiology working group on coronary pathophysiology & microcirculation endorsed by Coronary Vasomotor Disorders International Study Group.EuroIntervention2021;16:1049-69

[29] Kuvin JT.Clinical utility of endothelial function testing: ready for prime time?.Circulation2003;107:3243-7

[30] Neeland IJ,Eshtehardi P.Coronary angiographic scoring systems: an evaluation of their equivalence and validity.Am Heart J2012;164:547-552.e1 PMCID:PMC3913177